{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:37:19Z","timestamp":1772602639732,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A significant proportion of newly diagnosed patients with cutaneous squamous cell carcinoma (cSCC) have metastasis and eventually die of the disease, necessitating the exploration of novel biomarkers for early detection of cSCC aggressiveness, risk assessment and monitoring. Matrix metalloproteinase-13 (MMP-13) has been implicated in cSCC pathogenesis. Serum MMP-13 levels have been shown to predict survival in patients with esophageal SCC, but their diagnostic value for cSCC has not been explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a case-control study to examine serum MMP-13 as a biomarker for cSCC. Patients with cSCC undergoing surgical resection and health controls undergoing plastic surgery were recruited. ELISA for measurement of serum MMP-13 and immunohistochemistry for detection of tissue MMP-13 were performed, and the results were compared between the case and the control group, and among different patient groups. ROC curve analysis was performed to determine the diagnostic value of serum MMP-13 levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The ratio of male to female, and the age between the case (<jats:italic>n<\/jats:italic>\u2009=\u200977) and the control group (<jats:italic>n<\/jats:italic>\u2009=\u200950) were not significantly different. Patients had significantly higher serum MMP-13 levels than healthy controls. Subjects with stage 3 cSCC had markedly higher serum MMP-13 levels than those with stage 1 and stage 2 cSCC. Patients with invasive cSCC had remarkably higher serum MMP-13 than those with cSCC in situ. Post-surgery serum MMP-13 measurement was done in 12 patients, and a significant MMP-13 decrease was observed after removal of cSCC. Tumor tissues had a remarkably higher level of MMP-13 than control tissues. Serum MMP-13 predicted the presence of invasive cSCC with an AUC of 0.87 (95% CI [0.78 to 0.95]) for sensitivity and specificity of 81.7 and 82.4%, respectively for a cut-off value of 290\u2009pg\/mL. Serum MMP-13 predicted lymph node involvement with an AUC of 0.94 (95% CI [0.88 to 0.99]) for sensitivity and specificity of 93.8 and 88.5%, respectively for a cut-off value of 430\u2009pg\/mL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Serum MMP-13 might serve as a valuable biomarker for early detection of cSCC invasiveness and monitoring of cSCC progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08566-1","type":"journal-article","created":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:10:30Z","timestamp":1626376230000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma"],"prefix":"10.1186","volume":"21","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingtao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"issue":"5","key":"8566_CR1","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/cells9051076","volume":"9","author":"H Laronha","year":"2020","unstructured":"Laronha H, Caldeira J. Structure and function of human matrix metalloproteinases. Cells. 2020;9(5):1076. https:\/\/doi.org\/10.3390\/cells9051076.","journal-title":"Cells."},{"key":"8566_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005.","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"11\u201312","key":"8566_CR3","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.mod.2008.07.005","volume":"125","author":"ML Tomlinson","year":"2008","unstructured":"Tomlinson ML, Garcia-Morales C, Abu-Elmagd M, Wheeler GN. Three matrix metalloproteinases are required in vivo for macrophage migration during embryonic development. Mech Dev. 2008;125(11\u201312):1059\u201370. https:\/\/doi.org\/10.1016\/j.mod.2008.07.005.","journal-title":"Mech Dev"},{"issue":"13","key":"8566_CR4","doi-asserted-by":"publisher","first-page":"2813","DOI":"10.1002\/jnr.21273","volume":"85","author":"IM Ethell","year":"2007","unstructured":"Ethell IM, Ethell DW. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J Neurosci Res. 2007;85(13):2813\u201323. https:\/\/doi.org\/10.1002\/jnr.21273.","journal-title":"J Neurosci Res"},{"issue":"6","key":"8566_CR5","doi-asserted-by":"publisher","first-page":"3028","DOI":"10.1091\/mbc.e04-12-1119","volume":"16","author":"N Ortega","year":"2005","unstructured":"Ortega N, Behonick DJ, Colnot C, Cooper DN, Werb Z. Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation. Mol Biol Cell. 2005;16(6):3028\u201339. https:\/\/doi.org\/10.1091\/mbc.e04-12-1119.","journal-title":"Mol Biol Cell"},{"issue":"5","key":"8566_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1172\/JCI10910","volume":"106","author":"B Dubois","year":"2000","unstructured":"Dubois B, Arnold B, Opdenakker G. Gelatinase B deficiency impairs reproduction. J Clin Invest. 2000;106(5):627\u20138. https:\/\/doi.org\/10.1172\/JCI10910.","journal-title":"J Clin Invest"},{"issue":"2","key":"8566_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1582-4934.2005.tb00355.x","volume":"9","author":"JE Rundhaug","year":"2005","unstructured":"Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med. 2005;9(2):267\u201385. https:\/\/doi.org\/10.1111\/j.1582-4934.2005.tb00355.x.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"8566_CR8","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1074\/jbc.M107611200","volume":"277","author":"R Mohan","year":"2002","unstructured":"Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J Biol Chem. 2002;277(3):2065\u201372. https:\/\/doi.org\/10.1074\/jbc.M107611200.","journal-title":"J Biol Chem"},{"issue":"6","key":"8566_CR9","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1136\/annrheumdis-2013-203375","volume":"73","author":"DP de Rooy","year":"2014","unstructured":"de Rooy DP, Zhernakova A, Tsonaka R, Willemze A, Kurreeman BA, Trynka G, et al. A genetic variant in the region of MMP-9 is associated with serum levels and progression of joint damage in rheumatoid arthritis. Ann Rheum Dis. 2014;73(6):1163\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203375.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"8566_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/kei025","volume":"44","author":"NJ Peake","year":"2005","unstructured":"Peake NJ, Khawaja K, Myers A, Jones D, Cawston TE, Rowan AD, et al. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study. Rheumatology. 2005;44(11):1383\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/kei025.","journal-title":"Rheumatology."},{"issue":"3","key":"8566_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti MP, Brinckerhoff CE. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 2002;4(3):157\u201364. https:\/\/doi.org\/10.1186\/ar401.","journal-title":"Arthritis Res"},{"issue":"2","key":"8566_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1242\/dmm.012062","volume":"7","author":"M Giannandrea","year":"2014","unstructured":"Giannandrea M, Parks WC. Diverse functions of matrix metalloproteinases during fibrosis. Dis Model Mech. 2014;7(2):193\u2013203. https:\/\/doi.org\/10.1242\/dmm.012062.","journal-title":"Dis Model Mech"},{"key":"8566_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.matbio.2015.01.004","volume":"44\u201346","author":"S Duarte","year":"2015","unstructured":"Duarte S, Baber J, Fujii T, Coito AJ. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biol. 2015;44\u201346:147\u201356.","journal-title":"Matrix Biol"},{"issue":"1","key":"8566_CR14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12931-016-0343-6","volume":"17","author":"A Pardo","year":"2016","unstructured":"Pardo A, Cabrera S, Maldonado M, Selman M. Role of matrix metalloproteinases in the pathogenesis of idiopathic pulmonary fibrosis. Respir Res. 2016;17(1):23. https:\/\/doi.org\/10.1186\/s12931-016-0343-6.","journal-title":"Respir Res"},{"issue":"3","key":"8566_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc745","volume":"2","author":"M Egeblad","year":"2002","unstructured":"Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2(3):161\u201374. https:\/\/doi.org\/10.1038\/nrc745.","journal-title":"Nat Rev Cancer"},{"issue":"18","key":"8566_CR16","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.7150\/jca.25666","volume":"9","author":"R Fukushima","year":"2018","unstructured":"Fukushima R, Kasamatsu A, Nakashima D, Higo M, Fushimi K, Kasama H, et al. Overexpression of translocation associated membrane protein 2 leading to cancer-associated matrix metalloproteinase activation as a putative metastatic factor for human oral cancer. J Cancer. 2018;9(18):3326\u201333. https:\/\/doi.org\/10.7150\/jca.25666.","journal-title":"J Cancer"},{"key":"8566_CR17","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.2147\/OTT.S136840","volume":"10","author":"D Yu","year":"2017","unstructured":"Yu D, Ye T, Xiang Y, Shi Z, Zhang J, Lou B, et al. Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells. Onco Targets Ther. 2017;10:4719\u201329. https:\/\/doi.org\/10.2147\/OTT.S136840.","journal-title":"Onco Targets Ther"},{"issue":"9","key":"8566_CR18","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.18632\/oncotarget.1932","volume":"5","author":"C Mehner","year":"2014","unstructured":"Mehner C, Hockla A, Miller E, Ran S, Radisky DC, Radisky ES. Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer. Oncotarget. 2014;5(9):2736\u201349. https:\/\/doi.org\/10.18632\/oncotarget.1932.","journal-title":"Oncotarget."},{"issue":"1","key":"8566_CR19","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12885-016-2846-4","volume":"16","author":"CC Hsu","year":"2016","unstructured":"Hsu CC, Huang SF, Wang JS, Chu WK, Nien JE, Chen WS, et al. Interplay of N-cadherin and matrix metalloproteinase 9 enhances human nasopharyngeal carcinoma cell invasion. BMC Cancer. 2016;16(1):800. https:\/\/doi.org\/10.1186\/s12885-016-2846-4.","journal-title":"BMC Cancer"},{"issue":"1","key":"8566_CR20","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/cancers6010366","volume":"6","author":"AH Said","year":"2014","unstructured":"Said AH, Raufman JP, Xie G. The role of matrix metalloproteinases in colorectal cancer. Cancers. 2014;6(1):366\u201375. https:\/\/doi.org\/10.3390\/cancers6010366.","journal-title":"Cancers."},{"issue":"10","key":"8566_CR21","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.cellsig.2013.06.004","volume":"25","author":"EJ Lee","year":"2013","unstructured":"Lee EJ, Lee SJ, Kim S, Cho SC, Choi YH, Kim WJ, et al. Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1\/2-mediated MMP-9\/NF-\u03baB\/AP-1 pathway: involvement of the p21WAF1 expression. Cell Signal. 2013;25(10):2025\u201338. https:\/\/doi.org\/10.1016\/j.cellsig.2013.06.004.","journal-title":"Cell Signal"},{"issue":"30","key":"8566_CR22","doi-asserted-by":"publisher","first-page":"5111","DOI":"10.1038\/sj.onc.1207678","volume":"23","author":"R Ala-aho","year":"2004","unstructured":"Ala-aho R, Ahonen M, George SJ, Heikkil\u00e4 J, Gr\u00e9nman R, Kallajoki M, et al. Targeted inhibition of human collagenase-3 (MMP-13) expression inhibits squamous cell carcinoma growth in vivo. Oncogene. 2004;23(30):5111\u201323. https:\/\/doi.org\/10.1038\/sj.onc.1207678.","journal-title":"Oncogene."},{"issue":"6","key":"8566_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/j.1365-2559.2007.02885.x","volume":"51","author":"A O'Grady","year":"2007","unstructured":"O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology. 2007;51(6):793\u2013804. https:\/\/doi.org\/10.1111\/j.1365-2559.2007.02885.x.","journal-title":"Histopathology."},{"key":"8566_CR24","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3389\/fmed.2019.00160","volume":"6","author":"K Tanese","year":"2019","unstructured":"Tanese K, Nakamura Y, Hirai I, Funakoshi T. Updates on the systemic treatment of advanced non-melanoma skin cancer. Front Med. 2019;6:160. https:\/\/doi.org\/10.3389\/fmed.2019.00160.","journal-title":"Front Med"},{"issue":"5","key":"8566_CR25","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40257-016-0207-3","volume":"17","author":"KA Burton","year":"2016","unstructured":"Burton KA, Ashack KA, Khachemoune A. Cutaneous squamous cell carcinoma: a review of high-risk and metastatic disease. Am J Clin Dermatol. 2016;17(5):491\u2013508. https:\/\/doi.org\/10.1007\/s40257-016-0207-3.","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"8566_CR26","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","volume":"5","author":"C Fitzmaurice","year":"2019","unstructured":"Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Abate D, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749\u201368.","journal-title":"JAMA Oncol"},{"issue":"5","key":"8566_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/jamadermatol.2013.3064","volume":"149","author":"A Wysong","year":"2013","unstructured":"Wysong A, Aasi SZ, Tang JY. Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. JAMA Dermatol. 2013;149(5):615\u20136. https:\/\/doi.org\/10.1001\/jamadermatol.2013.3064.","journal-title":"JAMA Dermatol"},{"issue":"10","key":"8566_CR28","doi-asserted-by":"publisher","first-page":"5732","DOI":"10.1128\/MCB.15.10.5732","volume":"15","author":"J D'Armiento","year":"1995","unstructured":"D'Armiento J, DiColandrea T, Dalal SS, Okada Y, Huang MT, Conney AH, et al. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol. 1995;15(10):5732\u20139. https:\/\/doi.org\/10.1128\/MCB.15.10.5732.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"8566_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S0092-8674(00)00139-2","volume":"103","author":"LM Coussens","year":"2000","unstructured":"Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 2000;103(3):481\u201390. https:\/\/doi.org\/10.1016\/S0092-8674(00)00139-2.","journal-title":"Cell."},{"issue":"2","key":"8566_CR30","first-page":"499","volume":"151","author":"N Johansson","year":"1997","unstructured":"Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol. 1997;151(2):499\u2013508.","journal-title":"Am J Pathol"},{"issue":"2","key":"8566_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0009-8981(99)00225-9","volume":"291","author":"A Pendas","year":"2000","unstructured":"Pendas A, Uria JA, Jimenez MG, Balbin M, Freije JP, Lopez-Otin C. An overview of collagenase-3 expression in malignant tumors and analysis of its potential value as a target in antitumor therapies. Clin Chim Acta. 2000;291(2):137\u201355. https:\/\/doi.org\/10.1016\/S0009-8981(99)00225-9.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"8566_CR32","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0002-9440(10)65293-5","volume":"154","author":"N Johansson","year":"1999","unstructured":"Johansson N, Vaalamo M, Gr\u00e9nman S, Hietanen S, Klemi P, Saarialho-Kere U, et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol. 1999;154(2):469\u201380. https:\/\/doi.org\/10.1016\/S0002-9440(10)65293-5.","journal-title":"Am J Pathol"},{"issue":"1","key":"8566_CR33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2407-4-42","volume":"4","author":"N Culhaci","year":"2004","unstructured":"Culhaci N, Metin K, Copcu E, Dikicioglu E. Elevated expression of MMP-13 and TIMP-1 in head and neck squamous cell carcinomas may reflect increased tumor invasiveness. BMC Cancer. 2004;4(1):42. https:\/\/doi.org\/10.1186\/1471-2407-4-42.","journal-title":"BMC Cancer"},{"issue":"7","key":"8566_CR34","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1158\/1078-0432.CCR-09-2525","volume":"16","author":"A Stokes","year":"2010","unstructured":"Stokes A, Joutsa J, Ala-Aho R, Pitchers M, Pennington CJ, Martin C, et al. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res. 2010;16(7):2022\u201335. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-2525.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"8566_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, et al. The eighth edition AJCC Cancer staging manual: continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139. https:\/\/doi.org\/10.3322\/caac.21388.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"8566_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4132\/jptm.2016.08.08","volume":"50","author":"SW Kim","year":"2016","unstructured":"Kim SW, Roh J, Park CS. Immunohistochemistry for pathologists: protocols, pitfalls, and tips. J Pathol Transl Med. 2016;50(6):411\u20138. https:\/\/doi.org\/10.4132\/jptm.2016.08.08.","journal-title":"J Pathol Transl Med"},{"key":"8566_CR37","doi-asserted-by":"publisher","first-page":"4517492","DOI":"10.1155\/2016\/4517492","volume":"2016","author":"V Voiculescu","year":"2016","unstructured":"Voiculescu V, Calenic B, Ghita M, Lupu M, Caruntu A, Moraru L, et al. From normal skin to squamous cell carcinoma: a quest for novel biomarkers. Dis Markers. 2016;2016:4517492.","journal-title":"Dis Markers"},{"issue":"7","key":"8566_CR38","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.3390\/jcm9072228","volume":"9","author":"AD Lazar","year":"2020","unstructured":"Lazar AD, Dinescu S, Costache M. Deciphering the molecular landscape of cutaneous squamous cell carcinoma for better diagnosis and treatment. J Clin Med. 2020;9(7):2228. https:\/\/doi.org\/10.3390\/jcm9072228.","journal-title":"J Clin Med"},{"issue":"4","key":"8566_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5306\/wjco.v4.i4.85","volume":"4","author":"A Kivisaari","year":"2013","unstructured":"Kivisaari A, K\u00e4h\u00e4ri VM. Squamous cell carcinoma of the skin: emerging need for novel biomarkers. World J Clin Oncol. 2013;4(4):85\u201390. https:\/\/doi.org\/10.5306\/wjco.v4.i4.85.","journal-title":"World J Clin Oncol"},{"key":"8566_CR40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2144\/05384SU04","volume":"Suppl","author":"P Maruvada","year":"2005","unstructured":"Maruvada P, Wang W, Wagner PD, Srivastava S. Biomarkers in molecular medicine: cancer detection and diagnosis. Biotechniques. 2005;Suppl:9\u201315.","journal-title":"Biotechniques"},{"issue":"4","key":"8566_CR41","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2144\/btn-2018-0093","volume":"65","author":"JC Yeo","year":"2018","unstructured":"Yeo JC, Lim CT. Potential of circulating biomarkers in liquid biopsy diagnostics. Biotechniques. 2018;65(4):187\u20139. https:\/\/doi.org\/10.2144\/btn-2018-0093.","journal-title":"Biotechniques."},{"issue":"4","key":"8566_CR42","first-page":"509","volume":"18","author":"XL Jiao","year":"2014","unstructured":"Jiao XL, Chen D, Wang JG, Zhang KJ. Clinical significance of serum matrix metalloproteinase-13 levels in patients with esophageal squamous cell carcinoma (ESCC). Eur Rev Med Pharmacol Sci. 2014;18(4):509\u201315.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"5A","key":"8566_CR43","first-page":"3045","volume":"20","author":"F Riedel","year":"2000","unstructured":"Riedel F, G\u00f6tte K, Schwalb J, H\u00f6rmann K. Serum levels of matrix metalloproteinase-2 and -9 in patients with head and neck squamous cell carcinoma. Anticancer Res. 2000;20(5A):3045\u20139.","journal-title":"Anticancer Res"},{"issue":"8","key":"8566_CR44","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.7754\/Clin.Lab.2016.160139","volume":"62","author":"AE Stanciu","year":"2016","unstructured":"Stanciu AE, Zamfir-Chiru-Anton A, Stanciu MM, Popescu CR, Gheorghe DC. Serum level of matrix metalloproteinase-9 in patients with head and neck squamous cell carcinoma. Clin Lab. 2016;62(8):1569\u201374. https:\/\/doi.org\/10.7754\/Clin.Lab.2016.160139.","journal-title":"Clin Lab"},{"issue":"15","key":"8566_CR45","doi-asserted-by":"publisher","first-page":"6749","DOI":"10.7314\/APJCP.2015.16.15.6749","volume":"16","author":"A Lotfi","year":"2015","unstructured":"Lotfi A, Mohammadi G, Saniee L, Mousaviagdas M, Chavoshi H, Tavassoli A. Serum level of matrix metalloproteinase-2 and -9 in patients with laryngeal squamous cell carcinoma and clinical significance. Asian Pac J Cancer Prev. 2015;16(15):6749\u201351. https:\/\/doi.org\/10.7314\/APJCP.2015.16.15.6749.","journal-title":"Asian Pac J Cancer Prev"},{"key":"8566_CR46","doi-asserted-by":"publisher","first-page":"3136792","DOI":"10.1155\/2019\/3136792","volume":"2019","author":"M Matulka","year":"2019","unstructured":"Matulka M, Konopka A, Mroczko B, Pryczynicz A, Kemona A, Groblewska M, et al. Expression and concentration of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinases 1 in laryngeal squamous cell carcinoma. Dis Markers. 2019;2019:3136792.","journal-title":"Dis Markers"},{"issue":"3","key":"8566_CR47","doi-asserted-by":"publisher","first-page":"784","DOI":"10.5114\/aoms.2017.72405","volume":"15","author":"WL Grzelczyk","year":"2019","unstructured":"Grzelczyk WL, Wr\u00f3bel-Roztropi\u0144ski A, Szemraj J, Cybula M, Pietruszewska W, Zieli\u0144ska-Ka\u017amierska B, et al. Matrix metalloproteinases (MMPs) and inhibitor of metalloproteinases (TIMP) mRNA and protein expression in laryngeal squamous cell carcinoma. Arch Med Sci. 2019;15(3):784\u201391. https:\/\/doi.org\/10.5114\/aoms.2017.72405.","journal-title":"Arch Med Sci"},{"issue":"1","key":"8566_CR48","doi-asserted-by":"publisher","first-page":"252","DOI":"10.12669\/pjms.35.1.68","volume":"35","author":"N Choudhry","year":"2019","unstructured":"Choudhry N, Sarmad S, Waheed NUA, Gondal AJ. Estimation of serum matrix metalloproteinases among patients of oral squamous cell carcinoma. Pak J Med Sci. 2019;35(1):252\u20136. https:\/\/doi.org\/10.12669\/pjms.35.1.68.","journal-title":"Pak J Med Sci"},{"issue":"3","key":"8566_CR49","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s00784-016-1846-8","volume":"21","author":"NA Ghallab","year":"2017","unstructured":"Ghallab NA, Shaker OG. Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions. Clin Oral Investig. 2017;21(3):937\u201347. https:\/\/doi.org\/10.1007\/s00784-016-1846-8.","journal-title":"Clin Oral Investig"},{"issue":"12","key":"8566_CR50","first-page":"7431","volume":"34","author":"D Kalfert","year":"2014","unstructured":"Kalfert D, Ludvikova M, Topolcan O, Windrichova J, Malirova E, Pesta M, et al. Analysis of preoperative serum levels of MMP-1, \u22122, and \u22129 in patients with site-specific head and neck squamous cell cancer. Anticancer Res. 2014;34(12):7431\u201341.","journal-title":"Anticancer Res"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08566-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08566-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08566-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T19:11:30Z","timestamp":1626376290000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08566-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8566"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08566-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,15]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Review Committee of Weifang People\u2019s Hospital (Approval No.: 2016-3-10). Informed consent was obtained from all participants. All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"816"}}